Microbiome Therapeutics
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
182
NCT04056130
A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 4, 2019
Completion: Jan 7, 2020
NCT04307173
Study of Multiple Ascending Dose of KBL693 in Healthy Participants
Start: Aug 14, 2020
Completion: Nov 12, 2020
NCT04911751
A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
Phase: Phase 2
Start: Nov 8, 2021
Completion: Oct 7, 2024
NCT04898348
A Study to Investigate Efficacy and Safety of KBL697 in Patients With Mild to Moderate Active Ulcerative Colitis
Start: Jan 14, 2022
Completion: Jul 28, 2023
NCT06650644
A Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder for Improving Autism Spectrum Symptoms in Children With Autism Spectrum Symptoms.
Phase: N/A
Role: Collaborator
Start: Oct 10, 2024
Completion: Jul 23, 2025
Loading map...